Holy Cross Hospital is a 501 not-for-profit teaching hospital with revenue of $611 million located in Silver Spring, Maryland. The hospital, the second largest in Maryland, was founded in 1963 by the Sisters of the Holy Cross.

There are 529 beds in Holy Cross Hospital.

During the past decade, Holy Cross Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 35 clinical trials were completed, i.e. on average, 134.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 19 clinical trials were completed. i.e. 190% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Cross Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NSABP Foundation Inc" with 7 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Cross Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Holy Cross Hospital" are "Breast Cancer" (9 trials), "Recurrent Breast Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (5 trials), "HER2/Neu Negative" (4 trials) and "Stage II Breast Cancer" (4 trials). Many other conditions were trialed in "Holy Cross Hospital" in a lesser frequency.

Most popular intervention types in "Holy Cross Hospital" are "Drug" (53 trials), "Other" (29 trials), "Biological" (18 trials), "Radiation" (12 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Paclitaxel" (16 trials), "Quality-of-Life Assessment" (11 trials), "Bevacizumab" (10 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Holy Cross Hospital" are 40 trials for "All" genders, 27 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Holy Cross Hospital". undefined are not yet recruiting, 5 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Holy Cross Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Cross Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Holy Cross Hospital has several departments that took part in Clinical trials: "Holy Cross Hospital, Hospital Pharmacy" - 2 trials